Zebra Capital Management’s Natus Medical Inc NTUS Stock Holding History

Zebra Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,193	Closed	-$294K	–	115
2022 Q1	$294K	Sell	11,193 -1,053	-9%	-$25.7K	0.68%	56
2021 Q4	$291K	Sell	12,246 -4,515	-27%	-$111K	0.47%	70
2021 Q3	$420K	Sell	16,761 -7,712	-32%	-$196K	0.51%	61
2021 Q2	$636K	Sell	24,473 -2,642	-10%	-$71.9K	0.75%	46
2021 Q1	$694K	Buy	+27,115	New	+$695K	0.76%	44
2020 Q3	–	Sell	-9,870	Closed	-$215K	–	303
2020 Q2	$215K	Sell	9,870 -337	-3%	-$7.71K	0.31%	144
2020 Q1	$236K	Sell	10,207 -1,313	-11%	-$38.2K	0.38%	114
2019 Q4	$381K	Buy	+11,520	New	+$369K	0.34%	119
2019 Q3	–	Sell	-12,299	Closed	-$316K	–	467
2019 Q2	$316K	Buy	12,299 +2,323	+23%	+$59.2K	0.16%	248
2019 Q1	$253K	Buy	+9,976	New	+$298K	0.13%	319

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MAM

Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zebra Capital Management's NTUS Position: Q2 2022 in Review

Zebra Capital Management sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 11,193 shares — an estimated $294K sold.

Zebra Capital Management first reported a position in NTUS in Q1 2019 and held it in 10 quarters. The position peaked at $694K in Q1 2021. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

Zebra Capital Management reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
Zebra Capital Management sold 11,193 Natus Medical Inc shares in Q2 2022, an estimated $294K.
Zebra Capital Management first reported a position in Natus Medical Inc in Q1 2019 and held it in 10 quarters.
Zebra Capital Management's Natus Medical Inc position peaked at $694K in Q1 2021.
186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Zebra Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.